MedTrace Logo

Interest of EMDR Schizophrenic Disorders

NCT05164289 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 6

Last updated 2024-09-19

No results posted yet for this study

Summary

The purpose of this study is to determine the interest of the use of EMDR (Eye Movement Desensitization and Reprocessing) psychotherapy in the management of psychotic disorders, in particular schizophrenic disorders.

Conditions

  • Schizophrenic Disorders

Interventions

OTHER

Control group

Patients in the control group will have simple consultations on D15, D30, D45, D60 and D75

OTHER

EMDR group

Patients in the EMDR group will have EMDR session on D15, D30, D45, D60 and D75

Sponsors & Collaborators

  • Hôpital NOVO

    lead OTHER

Principal Investigators

  • Dr Marie-Claire ASMAR · Hospital René Dubos - Pontoise

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-12-10
Primary Completion
2022-04-27
Completion
2022-04-27

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05164289 on ClinicalTrials.gov